Prosecution Insights
Last updated: April 19, 2026
Application No. 17/105,439

ANTENNAS FOR A SUBCUTANEOUS DEVICE

Final Rejection §103
Filed
Nov 25, 2020
Examiner
KREMER, MATTHEW
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Calyan Technologies Inc.
OA Round
4 (Final)
44%
Grant Probability
Moderate
5-6
OA Rounds
4y 5m
To Grant
96%
With Interview

Examiner Intelligence

Grants 44% of resolved cases
44%
Career Allow Rate
196 granted / 448 resolved
-26.2% vs TC avg
Strong +52% interview lift
Without
With
+51.9%
Interview Lift
resolved cases with interview
Typical timeline
4y 5m
Avg Prosecution
58 currently pending
Career history
506
Total Applications
across all art units

Statute-Specific Performance

§101
6.2%
-33.8% vs TC avg
§103
35.5%
-4.5% vs TC avg
§102
14.0%
-26.0% vs TC avg
§112
36.2%
-3.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 448 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. No claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 3, 9-18, and 21-23 are rejected under 35 U.S.C. 103 as being unpatentable over U.S. Patent No. 10,471,251 (Manicka)(previously cited), in view of U.S. Patent Application Publication No. 2005/0288563 (Feliss)(previously cited), and further in view of U.S. Patent Application Publication No. 2010/0019985 (Bashyam)(previously cited), and further in view of U.S. Patent Application Publication No. 2011/0193751 (Golko)(previously cited). Manicka teaches a subcutaneously implantable device comprising: a housing (the housing 102, 402, 502, 602, 702, 802, 902, 1002, 1102, 1202, 1302, 1402, 1502 of Manicka); a clip (the clip 104, 404, 504, 604, 704, 804, 904, 1004, 1104, 1204, 1304, 1404, 1504 of Manicka) attached to the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue; circuitry (the power sources, the controller, the memory, the transceiver, the sensors, the sensing circuitry, the therapeutic circuitry, and the electrodes of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka) in the housing that is configured to provide monitoring, therapeutic, and/or diagnostic capabilities with respect to an organ, a nerve, the first tissue, and/or a second tissue, wherein the circuitry includes: a first power source (one of the power sources of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25- 50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka); and a transceiver (the transceiver 192 of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka); and a second antenna (the antenna connected to the transceiver 192 of Manicka; col. 14, line 55 to col. 15, line 12). Manicka teaches that one of the power sources is a rechargeable battery (col. 15, lines 10-20 of Manicka). Feliss teaches that rechargeable batteries 33 are recharged using a receiving coil 92 (FIG. 2 and paragraphs 0045 and 0090 of Feliss). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to include a receiver coil for recharging the battery of Manicka since it permits recharging of the battery of Manicka in a non-invasive fashion. Manicka teaches an antenna connected to the transceiver 192 of Manicka (col. 14, line 55 to col. 15, line 12). Bashyam teaches an antenna 102 connected to a transceiver 115 on the housing in the form of a header 100 and a housing 101 (paragraph 0034 and FIG. 2 of Bashyam). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to associate the antenna of Manicka with the housing, as suggested by Bashyam, since an arrangement for the antenna and transceiver is required and Bashyam teaches one such arrangement and/or it provides a suitable connection and protection for the antenna. The combination teaches or suggests a housing (the housing 102, 402, 502, 602, 702, 802, 902, 1002, 1102, 1202, 1302, 1402, 1502 of Manicka); a clip (the clip 104, 404, 504, 604, 704, 804, 904, 1004, 1104, 1204, 1304, 1404, 1504 of Manicka); circuitry (the power sources, the controller, the memory, the transceiver, the sensors, the sensing circuitry, the therapeutic circuitry, and the electrodes of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka); a first antenna (the receiving coil of the combination); and a second antenna (the antenna connected to the transceiver 192 of Manicka; col. 14, line 55 to col. 15, line 12 of Manicka). Golko teaches an antenna 108 that is attached to an external surface of an attachment member 104 of a clip (paragraphs 0024-0028 and FIGS. 1-4 of Golko).1 It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to place the antennae of the combination onto the external surface of the attachment portion of the clip of Manicka, as suggested by Golko, since (1) it is simple substitution of one known element for another to obtain predictable results and/or (2) it is a mere rearrangement of parts which does not impact the operation of the device and such a rearrangement has been held to be obvious (See MPEP 2144.04 citing In re Japikse, 181 F.2d 1019, 86 USPQ 70 (CCPA 1950) (Claims to a hydraulic power press which read on the prior art except with regard to the position of the starting switch were held unpatentable because shifting the position of the starting switch would not have modified the operation of the device.); and In re Kuhle, 526 F.2d 553, 188 USPQ 7 (CCPA 1975) (the particular placement of a contact in a conductivity measuring device was held to be an obvious matter of design choice)). With respect to claim 1, the combination teaches or suggests a subcutaneously implantable device comprising: a housing (the housing 102, 402, 502, 602, 702, 802, 902, 1002, 1102, 1202, 1302, 1402, 1502 of Manicka); a clip (the clip 104, 404, 504, 604, 704, 804, 904, 1004, 1104, 1204, 1304, 1404, 1504 of Manicka) attached to the housing and having an anchoring portion extending along a length of the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue of a patient; circuitry (the power sources, the controller, the memory, the transceiver, the sensors, the sensing circuitry, the therapeutic circuitry, and the electrodes of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka) in the housing that is configured to provide monitoring, therapeutic, and/or diagnostic capabilities with respect to an organ, a nerve, the first tissue, and/or a second tissue of the patient, wherein the circuitry includes: sensing circuitry and/or therapy circuitry (the therapeutic circuitry of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka); a first power source (one of the power sources of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25- 50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka); and a transceiver (the transceiver 192 of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka); a first antenna (the receiving coil of the combination) positioned on the anchoring portion of the clip (the receiving coil of the combination is positioned on the attachment portion of the clip; col. 14, line 55 to col. 15, line 12 of Manicka) and in electrical communication with the first power source; and a second antenna (the antenna connected to the transceiver 192 of Manicka; col. 14, line 55 to col. 15, line 12 of Manicka) positioned on the anchoring portion of the clip (the antenna connected to the transceiver 192 of Manicka is positioned on the attachment portion of the clip; col. 14, line 55 to col. 15, line 12 of Manicka) and in electrical communication with the transceiver; wherein the anchoring portion of the clip, the first antenna on the anchoring portion of the clip, and the second antenna on the anchoring portion of the clip are configured to be subcutaneously positioned in a body under a skin of the patient (Manicka discloses that the device (including the clip 104, 404, 504, 604, 704, 804, 904, 1004, 1104, 1204, 1304, 1404, 1504 of Manicka) is subcutaneously inserted through the skin (col. 20, line 46 to col. 22, line 66 and col. 23, lines 4-25 of Manicka). With respect to claim 3, the combination teaches or suggest that “the first antenna and the second antenna are positioned on a top side of the anchoring portion of the clip” since Golko teaches or suggests that the antenna are positioned on an external surface of an attachment member of a clip (paragraphs 0024-0028 and FIGS. 1-4 of Golko)2 and this external surface is considered to be a top side from the perspective of viewing the device from underneath. With respect to claim 9, the combination teaches or suggests that the first antenna is a recharging coil (the receiving coil of the combination). With respect to claim 10, the combination teaches or suggests that the first antenna is configured to receive power signals from a first external device and communicate the power signals to the first power source (the receiving coil of the combination is connected to the rechargeable battery of Manicka after receiving energy from an external power coil; paragraph 0090 of Feliss). With respect to claim 11, the combination teaches or suggests that the circuitry in the housing of the device further includes a second power source (another one of the power sources of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25- 50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka). With respect to claim 12, Manicka teaches a plurality of power sources (col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25- 50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka). Manicka teaches that one of the power sources is a rechargeable battery (col. 15, lines 10-20 of Manicka). Feliss teaches that rechargeable batteries 33 are recharged using a receiving coil 92 contained within the housing 39 (FIG. 2 and paragraphs 0045 and 0090 of Feliss). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to have the plurality of power sources of Manicka be rechargeable since it permits longer use of the power sources. Also, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the receiver coil inside the housing of Manicka for recharging all the batteries, as suggested by Feliss, since it permits recharging of all the batteries in a non-invasive fashion. Thus, the combination teaches or suggests that the first antenna is configured to receive power signals and communicate the power signals to the first power source and the second power source (the receiving coil of the combination is connected to the rechargeable batteries after receiving energy from an external power coil; paragraph 0090 of Feliss). With respect to claim 13, the combination teaches or suggests that the second antenna is a Bluetooth chip, wifi, or cellular antenna (the antenna connected to the transceiver 192 of Manicka uses network interfaces including Bluetooth or WiFi; col. 14, line 55 to col. 15, line 12 of Manicka). With respect to claim 14, the combination teaches or suggests that the second antenna is configured to receive data signals from a first external device and communicate the data signals to the transceiver (the antenna connected to the transceiver 192 of Manicka has this ability; col. 13, lines 30-45 of Manicka; col. 14, line 55 to col. 15, line 12 of Manicka). With respect to claim 15, the combination teaches or suggests that the second antenna is configured to receive data signals from a first external device and communicate the data signals to the transceiver to provide instructions to the device regarding the monitoring and therapeutic capabilities of the device (col. 13, lines 30-45 of Manicka; col. 14, line 55 to col. 15, line 12 of Manicka). With respect to claim 16, the combination teaches or suggests that the device is configured to be anchored to a xiphoid process of the patient (the ability to anchor to the xiphoid process of Manicka; FIGS. 8-9C, 23A-23C, 25A-25B, 28, 32A-32C, 37 of Manicka). With respect to claim 17, the combination teaches or suggests an electrode (the electrodes of Manicka) that is configured to contact the organ, the nerve, the first tissue, and/or the second tissue; wherein the circuitry in the housing is in electrical communication with the electrode to provide the monitoring, therapeutic, and/or diagnostic capabilities with respect to the organ, the nerve, the first tissue, and/or the second tissue (abstract; col. 1, line 45 to col. 2, line 27; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka). With respect to claim 18, the combination teaches or suggests a subcutaneously implantable device comprising: a housing (the housing 102, 402, 502, 602, 702, 802, 902, 1002, 1102, 1202, 1302, 1402, 1502 of Manicka); a clip attached to the housing and having an anchoring portion extending along a length of the housing that is configured to anchor the device to a muscle, a bone, and/or a first tissue of a patient (the clip 104, 404, 504, 604, 704, 804, 904, 1004, 1104, 1204, 1304, 1404, 1504 of Manicka); circuitry (the power sources, the controller, the memory, the transceiver, the sensors, the sensing circuitry, the therapeutic circuitry, and the electrodes of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka) in the housing that is configured to provide monitoring, therapeutic, and/or diagnostic capabilities with respect to an organ, a nerve, the first tissue, and/or a second tissue of the patient, wherein the circuitry includes: sensing circuitry and/or therapy circuitry (the therapeutic circuitry and/or the electrodes of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka); a first power source (one of the power sources of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25- 50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka); and a transceiver (the transceiver 192 of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka); and at least one antenna (the receiving coil of the combination; the antenna connected to the transceiver 192 of Manicka; col. 14, line 55 to col. 15, line 12 of Manicka) positioned on the anchoring portion of the clip (the receiving coil of the combination and the antenna connected to the transceiver 192 of Manicka are positioned on the clip; col. 14, line 55 to col. 15, line 12 of Manicka) and in electrical communication with the first power source (one of the power sources of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25- 50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka) and the transceiver (the transceiver 192 of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25-50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka); wherein the anchoring portion of the clip and the at least one antenna on the anchoring portion of the clip are configured to be subcutaneously positioned in a body under a skin of the patient (Manicka discloses that the device (including the clip 104, 404, 504, 604, 704, 804, 904, 1004, 1104, 1204, 1304, 1404, 1504 of Manicka) is subcutaneously inserted through the skin (col. 20, line 46 to col. 22, line 66 and col. 23, lines 4-25 of Manicka). With respect to claim 21, the combination teaches or suggests that the at least one antenna includes a first antenna (the receiving coil of the combination) that is in electrical communication with the first power source (one of the power sources of Manicka; col. 7, lines 40-58; col. 13, lines 5-52; col. 14, lines 35-45; col. 24, lines 35-60; col. 25, line 55 to col. 26, line 12; col. 27, lines 35-55; col. 29, lines 10-40; col. 30, line 55 to col. 31, line 10; col. 32, lines 25- 50; col. 33, line 63 to col. 34, line 20; col. 35, line 45 to col. 36, line 10; col. 37, line 55 to col. 38, line 10; col. 39, line 55 to col. 40, line 20; col. 42, lines 20-50; col. 44, line 5 to col. 45, line 5 of Manicka) and a second antenna (the antenna connected to the transceiver 192 of Manicka; col. 14, line 55 to col. 15, line 12 of Manicka) that is in electrical communication with the transceiver (the transceiver 192 of Manicka; col. 14, line 55 to col. 15, line 12 of Manicka). With respect to claim 22, the combination teaches or suggests that the first antenna is configured to receive power signals from a first external device and communicate the power signals to the first power source (the receiving coil of the combination is connected to the rechargeable battery of Manicka after receiving energy from an external power coil; paragraph 0090 of Feliss), and wherein the second antenna is configured to receive data signals from the first external device and/or a second external device and communicate the data signals to the transceiver (the antenna connected to the transceiver 192 of Manicka has this ability; col. 13, lines 30-45 of Manicka; col. 14, line 55 to col. 15, line 12 of Manicka). With respect to claim 23, the combination teaches or suggests that the device is configured to be anchored to a sternum of the patient (the ability to anchor to the xiphoid process of Manicka; FIGS. 8-9C, 23A-23C, 25A-25B, 28, 32A-32C, 37 of Manicka). Response to Arguments The Applicant’s arguments filed 10/3/2025 have been fully considered. Claim objections In view of the claim amendments filed on 10/3/2025, the claim objections are withdrawn. Prior art rejections The Applicant’s arguments with respect to claims 1, 3, 9-18, and 21-23 have been considered, but they are not persuasive. The Applicant asserts that Manicka, Feliss, and Bashyam do not teach the placement of the antennae on the anchoring portion of the claim. The Examiner agrees. The Examiner relies upon Golko for teaching an antenna 108 that is attached to an external surface of an attachment member 104 of a clip (paragraphs 0024-0028 and FIGS. 1-4 of Golko). The Applicant asserts that Golko3 does not disclose a medical device that is subcutaneously implanted under a skin of the patient. This position is not persuasive since the combination of Manicka, Feliss, and Bashyam teaches a medical device that is subcutaneously implanted under a skin of the patient. For example, Manicka discloses that the device (including the clip 104, 404, 504, 604, 704, 804, 904, 1004, 1104, 1204, 1304, 1404, 1504 of Manicka) is subcutaneously inserted through the skin (col. 20, line 46 to col. 22, line 66 and col. 23, lines 4-25 of Manicka). Also, Feliss teaches that rechargeable batteries 33 are recharged using a receiving coil 92 (FIG. 2 and paragraphs 0045 and 0090 of Feliss) in an implanted device (paragraphs 0018 and 0034-0035 of Feliss). Further, Bashyam teaches an antenna 102 connected to a transceiver 115 on the housing in the form of a header 100 and a housing 101 in an implanted device (paragraph 0034 and FIG. 2 of Bashyam). One cannot show nonobviousness by attacking references individually where the rejections are based on combinations of references. See In re Keller, 642 F.2d 413, 208 USPQ 871 (CCPA 1981); In re Merck & Co., 800 F.2d 1091, 231 USPQ 375 (Fed. Cir. 1986). The Applicant asserts: PNG media_image1.png 359 911 media_image1.png Greyscale This argument is not persuasive. As pointed out above, the combination of Manicka, Feliss, and Bashyam teaches a medical device (with its housing, clip, and antennae) that is subcutaneously implanted under a skin of the patient. For example, Manicka discloses that the device (including the clip 104, 404, 504, 604, 704, 804, 904, 1004, 1104, 1204, 1304, 1404, 1504 of Manicka) is subcutaneously inserted through the skin (col. 20, line 46 to col. 22, line 66 and col. 23, lines 4-25 of Manicka). Also, Feliss teaches that rechargeable batteries 33 are recharged using a receiving coil 92 (FIG. 2 and paragraphs 0045 and 0090 of Feliss) in an implanted device (paragraphs 0018 and 0034-0035 of Feliss). Further, Bashyam teaches an antenna 102 connected to a transceiver 115 on the housing in the form of a header 100 and a housing 101 in an implanted device (paragraph 0034 and FIG. 2 of Bashyam). Golko is merely relied upon to show where an antennae is placed when considering a structure with a housing and clip. That is, Golko is relied upon to show placement of the antennae on the physical structure, not the placing of the antenna subcutaneously under the skin per se. The Applicant asserts: PNG media_image2.png 634 904 media_image2.png Greyscale This argument is not persuasive. As pointed out above, the combination of Manicka, Feliss, and Bashyam teaches a medical device (with its housing, clip, and antennae) that is subcutaneously implanted under a skin of the patient. Golko is reasonably pertinent to the problem of placement of the antennae with respect to a structure having a housing and clip. As such, Golko is instructive in such a placement. Because Golko is reasonably pertinent to this problem, it is analogous art. In view of the above, the combination of Manicka, Feliss, Bashyam, and Golko renders the claim obvious and therefore not patentable. Claims 3, 9-17, and 23 are properly rejected since claim 1 is properly rejected and the prior art teaches or suggests these features of these claims. Claim 18 and its dependent claims 21-22 are properly rejected for the same reasons that claim 1 is properly rejected and the prior art teaches or suggests the features of these claims. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to MATTHEW KREMER whose telephone number is (571)270-3394. The examiner can normally be reached Monday - Friday 8 am to 6 pm; every other Friday off. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, JACQUELINE CHENG can be reached at (571) 272-5596. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /MATTHEW KREMER/Primary Examiner, Art Unit 3791 1 FIG. 2 of U.S. Patent No. 6,118,882 (Haynes)(previously cited) also teaches a transmitting terminal or antenna 24 on an exterior surface of an attachment portion of a clip 20 (see also claim 26 of Haynes). Also, paragraph 0119 of U.S. Patent Application Publication No. 2022/0084663 (Gumbel)(previously cited) teaches that an antennae 1856 may be built into an exterior clip of a communication device 1800 or may reside completely within the housing 1802 of the communication device 1800 (paragraph 0119 of Gumbel). 2 FIG. 2 of Haynes also teaches a transmitting terminal or antenna 24 on an exterior surface of an attachment portion of a clip 20 (see also claim 26 of Haynes). . 3 The Applicant also refers to the references of Haynes and Gumbel in the argument. However, Haynes and Gumbel were not explicitly used to reject the claims. As such, it is not necessary to directly address the teachings of these references. However, it should be noted that the arguments regarding Golko are equally applicable to Haynes and Gumbel if they were used in prior art rejections.
Read full office action

Prosecution Timeline

Nov 25, 2020
Application Filed
Jan 24, 2024
Non-Final Rejection — §103
Jul 01, 2024
Response Filed
Aug 19, 2024
Final Rejection — §103
Nov 22, 2024
Response after Non-Final Action
Dec 02, 2024
Response after Non-Final Action
Dec 12, 2024
Request for Continued Examination
Dec 15, 2024
Response after Non-Final Action
Apr 01, 2025
Non-Final Rejection — §103
Oct 03, 2025
Response Filed
Oct 16, 2025
Final Rejection — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594008
PUSH-TO-CHARGE LANCING DEVICE
2y 5m to grant Granted Apr 07, 2026
Patent 12594220
METHOD AND APPARATUS FOR MONITORING MANUAL CHEST COMPRESSION EFFICIENTLY DURING CPR
2y 5m to grant Granted Apr 07, 2026
Patent 12558075
DEVICE FOR COLLECTING A BIOLOGICAL SAMPLE
2y 5m to grant Granted Feb 24, 2026
Patent 12484825
STRETCH-DEFORMING ELECTRODE AND BIOLOGICAL SENSING SYSTEM
2y 5m to grant Granted Dec 02, 2025
Patent 12419619
ASPIRATION DEVICE
2y 5m to grant Granted Sep 23, 2025
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

5-6
Expected OA Rounds
44%
Grant Probability
96%
With Interview (+51.9%)
4y 5m
Median Time to Grant
High
PTA Risk
Based on 448 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month